EV/EBITDA
-2.50
-0.13-5.49%
Wed, 12 Mar 2025 22:48:29 GMT
Summary
- As of March 13, 2025, NRSN EV/EBITDA is -2.50, with a fall of -0.13 (-5.49%) during the most recent trading day.
- Over the past year, NRSN EV/EBITDA has dropped by -0.40 (-19.05%).
- NRSN EV/EBITDA is now -2400.00% below its all-time high of -0.10.
Performance
NRSN EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
NRSN EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -5.5% | +5.5% | +5.4% |
| 1 m1 month | +2.7% | -2.8% | -2.7% |
| 3 m3 months | -23.1% | +22.7% | +22.4% |
| 6 m6 months | -9.2% | +9.1% | -8.2% |
| ytdytd | +3.5% | -3.6% | -3.5% |
| 1 y1 year | -19.1% | +10.1% | -28.0% |
| 5 y5 years | - | - | - |
NRSN EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -8.7% | -2.61 | +4.2% | |
| 3 m | 3-month | -1.90 | -31.6% | -3.03 | +17.5% |
| 6 m | 6-month | -1.71 | -46.2% | -3.03 | +17.5% |
| 1 y | 1-year | -0.93 | -168.8% | -3.03 | +17.5% |
| 3 y | 3-year | -0.10 | -2400.0% | -14.13 | +82.3% |
| 5 y | 5-year | -0.10 | -2400.0% | -14.13 | +82.3% |
| alltime | all time | -0.10 | -2400.0% | -14.13 | +82.3% |
NeuroSense Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -2.50(-3.5%) |
| 2024 | -2.59(+194.3%) |
| Date | Value |
|---|---|
| 2023 | -0.88(-2.2%) |
| 2022 | -0.90(-77.0%) |
| 2021 | -3.92 |
FAQ
- What is NeuroSense Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for NeuroSense Therapeutics?
- What is NRSN EV/EBITDA year-to-date change?
- What is NeuroSense Therapeutics EV/EBITDA year-on-year change?
What is NeuroSense Therapeutics EV/EBITDA?
The current EV/EBITDA of NRSN is -2.50
What is the all time high EV/EBITDA for NeuroSense Therapeutics?
NeuroSense Therapeutics all-time high EV/EBITDA is -0.10
What is NRSN EV/EBITDA year-to-date change?
NeuroSense Therapeutics EV/EBITDA has changed by +0.09 (+3.47%) since the beginning of the year
What is NeuroSense Therapeutics EV/EBITDA year-on-year change?
Over the past year, NRSN EV/EBITDA has changed by -0.40 (-19.05%)